Department of Clinical Laboratory, Traditional Chinese Medicine Hospital of Pidu District, No. 342, South Street, Pidu District, Chengdu, Sichuan, 611730, China.
Department of Clinical Laboratory, The Third People's Hospital of Chengdu, Chengdu, Sichuan, 610000, China.
Ir J Med Sci. 2024 Jun;193(3):1613-1620. doi: 10.1007/s11845-024-03621-9. Epub 2024 Feb 3.
Use the MDRD (Modification of Diet in Renal Disease) and 2021 CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) equation void of race coefficients (CKD-EPI, CKD-EPI, and CKD-EPI) to estimate the BV (Biological variation) of eGFR (estimated glomerular filtration rate) within 24 h in a healthy population to help explain future studies using eGFR in the context of a known BV.
Blood samples were collected from 30 healthy subjects at six time points within 24 h. Serum creatinine (S-Crea) and serum cystatin C (S-Cys-C) were measured, and the BV of eGFR was calculated. Outlier and variance homogeneity analyses were performed, followed by CV-ANOVA on trend-corrected data.
The eGFR CV for the four equations (MDRD, CKD-EPI, CKD-EPI, and CKD-EPI) were 8.39% (7.50-9.51%), 3.90% (3.49-4.42%), 6.58% (5.88-7.46%), and 5.03% (4.50-5.71%), respectively. The corresponding II and RCV values were 0.69, 0.48, 0.51, and 0.31, and (29.30%, - 22.66%), (12.69%, - 11.2 6%), (20.97%, - 17.33%), and (15.88%, - 13.70%), respectively; RCV of eGFR was highest in the MDRD equation and lowest in the CKD-EPI equation. Additionally, the RCV values of the individual was highest in the MDRD equation and lowest in the CKD-EPI equation; they are (56.51%, - 36.11%) and (5.01%, - 4.77%), respectively.
We present data on the 24 h BV eGFR of the 2021 CKD-EPI equations. The presence of BV has impact on the interpretation of GFR results, affecting CKD disease grading. The RCV differences were large among the individuals. When using eGFRs based on the MDRD and CKD-EPI equations, it is necessary to combine RCV values before interpreting the results.
使用无种族系数的 MDRD(肾脏病饮食改良)和 2021 年 CKD-EPI(慢性肾脏病流行病学合作)方程(CKD-EPI、CKD-EPI 和 CKD-EPI)来估计健康人群中 24 小时内 eGFR(估算肾小球滤过率)的 BV(生物学变异),以帮助解释未来在已知 BV 背景下使用 eGFR 的研究。
在 24 小时内的六个时间点采集 30 名健康受试者的血样。测量血清肌酐(S-Crea)和血清胱抑素 C(S-Cys-C),计算 eGFR 的 BV。进行离群值和方差同质性分析,然后对趋势校正后的数据进行 CV-ANOVA。
四个方程(MDRD、CKD-EPI、CKD-EPI 和 CKD-EPI)的 eGFR CV 分别为 8.39%(7.50-9.51%)、3.90%(3.49-4.42%)、6.58%(5.88-7.46%)和 5.03%(4.50-5.71%)。相应的 II 和 RCV 值分别为 0.69、0.48、0.51 和 0.31,(29.30%,-22.66%)、(12.69%,-11.26%)、(20.97%,-17.33%)和(15.88%,-13.70%)。eGFR 的 RCV 在 MDRD 方程中最高,在 CKD-EPI 方程中最低。此外,MDRD 方程中个体的 RCV 值最高,在 CKD-EPI 方程中最低;分别为(56.51%,-36.11%)和(5.01%,-4.77%)。
我们提供了 2021 年 CKD-EPI 方程 24 小时 eGFR 生物学变异的数据。BV 的存在对 GFR 结果的解释有影响,影响 CKD 疾病分级。个体间的 RCV 差异较大。当使用基于 MDRD 和 CKD-EPI 方程的 eGFR 时,在解释结果之前需要结合 RCV 值。